We can conclude that erythropoietin represents one of the most important growth factors that, together with other angiogenic factors, like vascular endothelial factor, participates in ischemic and angiogenic processes in diabetic retinopathy, especially at its proliferative stage. Here, EPO is linked to diabetic retinopathy.